[go: up one dir, main page]

UA92641C2 - Комбинированная препаративная форма, которая содержит амлодипин и лозартан - Google Patents

Комбинированная препаративная форма, которая содержит амлодипин и лозартан

Info

Publication number
UA92641C2
UA92641C2 UAA200814649A UAA200814649A UA92641C2 UA 92641 C2 UA92641 C2 UA 92641C2 UA A200814649 A UAA200814649 A UA A200814649A UA A200814649 A UAA200814649 A UA A200814649A UA 92641 C2 UA92641 C2 UA 92641C2
Authority
UA
Ukraine
Prior art keywords
pharmaceutical composition
losartan
amlodipine
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
UAA200814649A
Other languages
English (en)
Ukrainian (uk)
Inventor
Дзонг-Соо Воо
Хонг Ги Йи
Моон-Хиук Чи
Киоунг Соо Ким
Original Assignee
Ханми Фарм. Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39492408&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA92641(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ханми Фарм. Ко., Лтд. filed Critical Ханми Фарм. Ко., Лтд.
Publication of UA92641C2 publication Critical patent/UA92641C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретение касается комбинированной препаративной формы для предотвращения или лечения сердечно-сосудистых расстройств, которая содержит физически отделенные друг от друга амлодипин или его фармацевтически приемлемую соль и лозартан или его фармацевтически приемлемую соль.
UAA200814649A 2006-12-08 2007-12-07 Комбинированная препаративная форма, которая содержит амлодипин и лозартан UA92641C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020060124552A KR101247583B1 (ko) 2006-12-08 2006-12-08 암로디핀 또는 이의 약제학적 허용가능한 염, 및 로자탄또는 이의 약제학적 허용가능한 염을 함유하는 약제학적조성물

Publications (1)

Publication Number Publication Date
UA92641C2 true UA92641C2 (ru) 2010-11-25

Family

ID=39492408

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200814649A UA92641C2 (ru) 2006-12-08 2007-12-07 Комбинированная препаративная форма, которая содержит амлодипин и лозартан

Country Status (19)

Country Link
US (1) US20100233261A1 (ru)
EP (1) EP2037917B1 (ru)
JP (1) JP4995912B2 (ru)
KR (1) KR101247583B1 (ru)
CN (1) CN101472587B (ru)
AU (1) AU2007328630B2 (ru)
BR (1) BRPI0713306A8 (ru)
CA (1) CA2654054C (ru)
EC (1) ECSP088980A (ru)
ES (1) ES2522567T3 (ru)
IL (1) IL195581A (ru)
MX (1) MX2008016099A (ru)
MY (1) MY144857A (ru)
NO (1) NO20085302L (ru)
NZ (1) NZ573223A (ru)
RU (1) RU2401107C2 (ru)
UA (1) UA92641C2 (ru)
WO (1) WO2008069612A1 (ru)
ZA (2) ZA200910116B (ru)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010085014A1 (en) * 2009-01-23 2010-07-29 Hanmi Pharm. Co., Ltd. Solid pharmaceutical composition comprising amlodipine and losartan and process for producing same
TWI503119B (zh) * 2009-01-23 2015-10-11 Hanmi Science Co Ltd 含有氨氯地平（ａｍｌｏｄｉｐｉｎｅ）及洛沙坦（ｌｏｓａｒｔａｎ）之固體藥學組成物及其製造方法
CN101849942B (zh) * 2009-04-02 2012-05-23 鲁南制药集团股份有限公司 治疗高血压的药物组合物
CN101849941B (zh) * 2009-04-02 2012-04-18 鲁南制药集团股份有限公司 一种治疗高血压的药物组合物
AU2009349125B2 (en) * 2009-06-30 2016-05-19 Sanofi Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine, their preparation and their therapeutic application
JP2011136908A (ja) * 2009-12-25 2011-07-14 Kyowa Yakuhin Kogyo Kk アンギオテンシンｉｉ受容体拮抗剤を含む固形製剤および固形製剤におけるアンギオテンシンｉｉ受容体拮抗剤の保存安定性向上方法
EP2632438A1 (en) * 2010-10-27 2013-09-04 KRKA, tovarna zdravil, d.d., Novo mesto Multilayer pharmaceutical composition comprising telmisartan and amlodipine
CN102335172B (zh) * 2011-07-20 2012-12-12 海南锦瑞制药股份有限公司 一种氨氯地平与氯沙坦钾药用组合物及其制备方法
KR101907881B1 (ko) * 2011-12-30 2018-12-11 한미약품 주식회사 로자탄, 암로디핀 및 히드로클로로티아자이드를 포함하는 고정 용량 조합 제형
KR101392364B1 (ko) * 2012-04-17 2014-05-07 한국유나이티드제약 주식회사 안정성이 향상된 암로디핀 및 로잘탄을 함유하는 복합제 조성물
KR101910901B1 (ko) * 2013-11-29 2018-10-24 한미약품 주식회사 암로디핀, 로자탄 및 로수바스타틴을 포함하는 약제학적 복합 제제
KR20150078215A (ko) * 2013-12-30 2015-07-08 (주) 드림파마 에프로사탄 및 암로디핀을 포함하는 복합제제 및 이의 제조방법
KR102369607B1 (ko) * 2014-09-30 2022-03-03 한미약품 주식회사 암로디핀 및 로잘탄을 포함하는 고형 약제학적 조성물
KR101914930B1 (ko) * 2015-03-31 2018-11-05 한미약품 주식회사 암로디핀, 로자탄 및 클로르탈리돈을 포함하는 약제학적 복합 제제
KR101750689B1 (ko) * 2015-09-15 2017-06-26 주식회사 종근당 약제학적 복합제제
KR101710441B1 (ko) * 2015-12-28 2017-02-28 신풍제약주식회사 안정성 및 용출성이 향상된 정제
CN110215455A (zh) * 2019-03-26 2019-09-10 山东省药学科学院 一种用于降血压的药物配方
CN112274490B (zh) * 2020-11-19 2022-11-22 四川尚锐生物医药有限公司 一种氨氯地平氯沙坦钾复方组合物的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69712338T2 (de) * 1996-06-24 2002-11-07 Merck & Co., Inc. Zusammensetzung auf basis von enalapril und losartan
WO2000027397A1 (en) * 1998-11-06 2000-05-18 Glaxo Group Limited Antihypertensive medicaments containing lacidipine and telmisartan
AU2001284413A1 (en) * 2000-08-30 2002-03-13 Sankyo Company Limited Medicinal compositions for preventing or treating heart failure
US20040137062A1 (en) * 2001-05-25 2004-07-15 Sham Chopra Chronotherapy tablet and methods related thereto
MXPA05007876A (es) * 2003-01-27 2005-09-21 Hanmi Pharm Ind Co Ltd Camsilato de amlodipino amorfo, estable, proceso para preparar el mismo y composicion para la administracion oral del mismo.
PL377344A1 (pl) * 2003-01-31 2006-01-23 Sankyo Company, Limited Lekarstwo do profilaktyki i leczenia miażdżycy tętnic i nadciśnienia
AR043395A1 (es) * 2003-02-28 2005-07-27 Recordati Ireland Ltd Terapia de combinacion para la hipertension utilizando lercanidipina y un bloqueante de los receptores de angiotensina ii
US20040253305A1 (en) * 2003-06-12 2004-12-16 Luner Paul E. Pharmaceutical compositions of atorvastatin
US20050209288A1 (en) * 2004-01-12 2005-09-22 Grogan Donna R Compositions comprising (S)-amlodipine malate and an angiotensin receptor blocker and methods of their use
US20060068010A1 (en) * 2004-09-30 2006-03-30 Stephen Turner Method for improving the bioavailability of orally delivered therapeutics
SI1814527T1 (sl) * 2004-11-05 2014-03-31 Boehringer Ingelheim International Gmbh Dvoslojna tableta, ki obsega telmisartan in amlodipin
WO2007001067A2 (en) * 2005-06-27 2007-01-04 Daiichi Sankyo Company, Limited Solid dosage form comprising an angiotensin ii receptor antagonist and a calcium channel blocker
KR100888131B1 (ko) * 2006-10-10 2009-03-11 한올제약주식회사 시간차 투약 원리를 이용한 심혈관계 질환 치료용 복합제제

Also Published As

Publication number Publication date
RU2008150477A (ru) 2010-06-27
MY144857A (en) 2011-11-30
NO20085302L (no) 2009-06-17
BRPI0713306A8 (pt) 2016-06-07
HK1131916A1 (en) 2010-02-12
EP2037917B1 (en) 2014-10-08
ES2522567T3 (es) 2014-11-17
JP2009544752A (ja) 2009-12-17
WO2008069612A1 (en) 2008-06-12
IL195581A (en) 2015-08-31
EP2037917A1 (en) 2009-03-25
RU2401107C2 (ru) 2010-10-10
NZ573223A (en) 2012-07-27
ECSP088980A (es) 2009-02-27
KR20080052852A (ko) 2008-06-12
CA2654054C (en) 2013-01-08
US20100233261A1 (en) 2010-09-16
ZA200910116B (en) 2010-07-28
BRPI0713306A2 (pt) 2012-04-17
MX2008016099A (es) 2009-01-19
IL195581A0 (en) 2009-09-01
CA2654054A1 (en) 2008-06-12
EP2037917A4 (en) 2010-08-04
AU2007328630A1 (en) 2008-06-12
JP4995912B2 (ja) 2012-08-08
ZA200810116B (en) 2010-07-28
CN101472587A (zh) 2009-07-01
AU2007328630B2 (en) 2010-03-11
KR101247583B1 (ko) 2013-03-26
CN101472587B (zh) 2013-11-20

Similar Documents

Publication Publication Date Title
UA92641C2 (ru) Комбинированная препаративная форма, которая содержит амлодипин и лозартан
TWI369987B (en) New pharmaceutical compositions for the treatment of hyper-proliferative disorders
IL251539A0 (en) Single pharmaceutical dosage form
GB0522311D0 (en) Pharmaceutical compositions for the treatment of pain
UA95975C2 (ru) N-метиламинометилизоиндольные соединения, композиции, содержащие их, и способы их применения
ZA200701557B (en) Pharmaceutical compositions comprising diclofenac
MX2012007375A (es) 3-ceto-n-propargil 1-aminoindano.
WO2008027542A3 (en) 5-substituted isoindoline compounds
IL190913B (en) Preparations for the treatment of sweating disorders
PL2083809T3 (pl) Kompozycja dietetyczna lub farmaceutyczna zawierająca tricykliczne diterpeny do leczenia depresji
UA93709C2 (ru) 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
GB0525680D0 (en) Therapeutic compositions
ZA200806778B (en) N-Hydroxyacrylamide compounds
IL185197A0 (en) Ophthalmological pharmaceutical compositions
IL197235A0 (en) Therapeutic compositions
IL192415A0 (en) Pharmaceutical composition for the treatment of nail diseases
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
UA97401C2 (ru) Экструдат с улучшенной маскировкой вкуса
EP2012807A4 (en) PHARMACEUTICAL COMPOSITION FROM AN ENTEROSORBEN AND PREBIOTIKA, DOSAGE FORMS AND METHOD FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DISEASES
IL193799A0 (en) New therapeutic combinations for the treatment or prevention of psycotic disorders
MX2010001243A (es) Composicion anti-inflamatoria.
ZA200803152B (en) Oramucosal pharmaceutical dosage form
WO2008081268A3 (en) Pharmaceutical compositions of entacapone
IL188831A0 (en) Compositions for reducing the incidence of drug induced arrhythmia
WO2008022807A3 (en) Lipoxin a4 analogs for the treatment and prevention of intestinal fibrosis